EquityZen Growth Technology Fund LLC - Series 105
Raised
$757K
Investors
37
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 105 is a Delaware pooled investment fund vehicle that raised $757K from 37 investors under Rule 506(b) and Section 3(c)(1) exemptions. This amended filing was submitted by EquityZen, a pre-IPO investment platform with over 1,800 related entities, with management involving EquityZen Inc, Shriram Bhashyam, Assure Fund Management II LLC, and Erin Rosenthal.
This offering represents a typical pre-IPO platform SPV structure using the 506(b) private placement exemption combined with Investment Company Act 3(c)(1) exclusion. The investor count of 37 and total raise of $757K yields an average commitment of approximately $20K per investor, consistent with retail-accessible pre-IPO platforms that aggregate smaller checks into single-company exposure vehicles.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Erin Rosenthal
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
